866-997-4948(US-Canada Toll Free)

Global Pregabalin Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 99 Pages

This report studies the global market size of Pregabalin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pregabalin in these regions.
This research report categorizes the global Pregabalin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
In 2017, the global Pregabalin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Pregabalin market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pregabalin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pregabalin include
Pfizer Inc.
Torrent Pharmaceuticals Ltd.
Lupin Limited
Zydus Cadila Healthcare Ltd.
Cipla Limited
Genesis Remedies
Sanofi
Medley Pharmaceuticals Limited
Genesis Biotec Inc.
Biomax

Market Size Split by Type
Epilepsy
Neuropathic Pain
Fibromyalgia
Generalized Anxiety Disorder
Market Size Split by Application
Research Institutes
Pharmaceutical Companies
Others (Hospitals and Clinics)

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pregabalin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Pregabalin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pregabalin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pregabalin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pregabalin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pregabalin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pregabalin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Pregabalin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pregabalin Market Size Growth Rate by Type
1.4.2 Epilepsy
1.4.3 Neuropathic Pain
1.4.4 Fibromyalgia
1.4.5 Generalized Anxiety Disorder
1.5 Market by Application
1.5.1 Global Pregabalin Market Size Growth Rate by Application
1.5.2 Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Others (Hospitals and Clinics)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pregabalin Market Size
2.1.1 Global Pregabalin Revenue 2016-2025
2.1.2 Global Pregabalin Sales 2016-2025
2.2 Pregabalin Growth Rate by Regions
2.2.1 Global Pregabalin Sales by Regions
2.2.2 Global Pregabalin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pregabalin Sales by Manufacturers
3.1.1 Pregabalin Sales by Manufacturers
3.1.2 Pregabalin Sales Market Share by Manufacturers
3.1.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
3.2 Pregabalin Revenue by Manufacturers
3.2.1 Pregabalin Revenue by Manufacturers (2016-2018)
3.2.2 Pregabalin Revenue Share by Manufacturers (2016-2018)
3.3 Pregabalin Price by Manufacturers
3.4 Pregabalin Manufacturing Base Distribution, Product Types
3.4.1 Pregabalin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pregabalin Product Category
3.4.3 Date of International Manufacturers Enter into Pregabalin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pregabalin Sales by Type
4.2 Global Pregabalin Revenue by Type
4.3 Pregabalin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pregabalin Breakdown Data by Application

6 North America
6.1 North America Pregabalin by Countries
6.1.1 North America Pregabalin Sales by Countries
6.1.2 North America Pregabalin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pregabalin by Type
6.3 North America Pregabalin by Application
6.4 North America Pregabalin by Company

7 Europe
7.1 Europe Pregabalin by Countries
7.1.1 Europe Pregabalin Sales by Countries
7.1.2 Europe Pregabalin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pregabalin by Type
7.3 Europe Pregabalin by Application
7.4 Europe Pregabalin by Company

8 Asia Pacific
8.1 Asia Pacific Pregabalin by Countries
8.1.1 Asia Pacific Pregabalin Sales by Countries
8.1.2 Asia Pacific Pregabalin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pregabalin by Type
8.3 Asia Pacific Pregabalin by Application
8.4 Asia Pacific Pregabalin by Company

9 Central & South America
9.1 Central & South America Pregabalin by Countries
9.1.1 Central & South America Pregabalin Sales by Countries
9.1.2 Central & South America Pregabalin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pregabalin by Type
9.3 Central & South America Pregabalin by Application
9.4 Central & South America Pregabalin by Company

10 Middle East and Africa
10.1 Middle East and Africa Pregabalin by Countries
10.1.1 Middle East and Africa Pregabalin Sales by Countries
10.1.2 Middle East and Africa Pregabalin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pregabalin by Type
10.3 Middle East and Africa Pregabalin by Application
10.4 Middle East and Africa Pregabalin by Company

11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Pregabalin
11.1.4 Pregabalin Product Description
11.1.5 Recent Development
11.2 Torrent Pharmaceuticals Ltd.
11.2.1 Torrent Pharmaceuticals Ltd. Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Pregabalin
11.2.4 Pregabalin Product Description
11.2.5 Recent Development
11.3 Lupin Limited
11.3.1 Lupin Limited Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Pregabalin
11.3.4 Pregabalin Product Description
11.3.5 Recent Development
11.4 Zydus Cadila Healthcare Ltd.
11.4.1 Zydus Cadila Healthcare Ltd. Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Pregabalin
11.4.4 Pregabalin Product Description
11.4.5 Recent Development
11.5 Cipla Limited
11.5.1 Cipla Limited Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Pregabalin
11.5.4 Pregabalin Product Description
11.5.5 Recent Development
11.6 Genesis Remedies
11.6.1 Genesis Remedies Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Pregabalin
11.6.4 Pregabalin Product Description
11.6.5 Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Pregabalin
11.7.4 Pregabalin Product Description
11.7.5 Recent Development
11.8 Medley Pharmaceuticals Limited
11.8.1 Medley Pharmaceuticals Limited Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Pregabalin
11.8.4 Pregabalin Product Description
11.8.5 Recent Development
11.9 Genesis Biotec Inc.
11.9.1 Genesis Biotec Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Pregabalin
11.9.4 Pregabalin Product Description
11.9.5 Recent Development
11.10 Biomax
11.10.1 Biomax Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Pregabalin
11.10.4 Pregabalin Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Pregabalin Raw Material
13.1.2 Pregabalin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Pregabalin
Figure Global Pregabalin Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Pregabalin Production Market Share by Types (Product Category) in 2017
Figure Epilepsy Product Picture
Table Major Manufacturers of Epilepsy
Figure Neuropathic Pain Product Picture
Table Major Manufacturers of Neuropathic Pain
Figure Fibromyalgia Product Picture
Table Major Manufacturers of Fibromyalgia
Figure Generalized Anxiety Disorder Product Picture
Table Major Manufacturers of Generalized Anxiety Disorder
Table Global Pregabalin Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Research Institutes
Figure Pharmaceutical Companies
Figure Others (Hospitals and Clinics)
Figure Pregabalin Report Years Considered
Figure Global Pregabalin Market Size 2016-2025 (Million US$)
Figure Global Pregabalin Sales 2016-2025 (K MT)
Table Global Pregabalin Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Pregabalin Sales by Regions 2016-2025 (K MT)
Table Global Pregabalin Sales Market Share by Regions 2016-2025
Figure Global Pregabalin Sales Market Share by Regions 2016-2025
Figure 2017 Global Pregabalin Sales Market Share by Regions
Table Global Pregabalin Revenue by Regions 2016-2025 (Million US$)
Table Global Pregabalin Revenue Market Share by Regions 2016-2025
Figure Global Pregabalin Revenue Market Share by Regions 2016-2025
Figure 2017 Global Pregabalin Revenue Market Share by Regions
Table Global Pregabalin Sales by Manufacturers (2016-2018) (K MT)
Table Global Pregabalin Sales Share by Manufacturers (2016-2018)
Figure Global Pregabalin Sales Share by Manufacturers in 2017
Table Pregabalin Revenue by Manufacturers (2016-2018) (Million US$)
Table Pregabalin Revenue Share by Manufacturers (2016-2018)
Figure Pregabalin Value Share by Manufacturers in 2017
Table Global Pregabalin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Pregabalin Price (2016-2018) (USD/MT)
Table Pregabalin Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pregabalin Product Category
Table Date of International Manufacturers Enter into Pregabalin Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pregabalin Sales by Type (2016-2025) (K MT)
Table Global Pregabalin Sales Share by Type (2016-2025)
Figure Global Pregabalin Sales Market Share by Type (2016-2025)
Figure Global Pregabalin Sales Market Share by Type in 2017
Table Global Pregabalin Revenue by Type (2016-2025) (Million US$)
Table Global Pregabalin Revenue Share by Type (2016-2025)
Figure Global Pregabalin Revenue Market Share by Type (2016-2025)
Figure Global Pregabalin Revenue Market Share by Type in 2017
Table Pregabalin Price by Type 2013-2018 (USD/MT)
Table Global Pregabalin Sales by Application (2016-2025) (K MT)
Table Global Pregabalin Sales Share by Application (2016-2025)
Figure Global Sales Pregabalin Market Share by Application (2016-2025)
Figure Global Sales Pregabalin Market Share by Application (2016-2025)
Figure North America Pregabalin Sales Growth Rate 2016-2025 (K MT)
Figure North America Pregabalin Revenue Growth Rate 2016-2025 (Million US$)
Table North America Pregabalin Sales by Countries (2016-2025) (K MT)
Table North America Pregabalin Sales Market Share by Countries (2016-2025)
Figure 2017 North America Pregabalin Sales Market Share by Countries
Table North America Pregabalin Revenue by Countries (2016-2025) (Million US$)
Table North America Pregabalin Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Pregabalin Revenue Market Share by Countries
Figure United States Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure United States Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Canada Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Table North America Pregabalin Sales by Type (2016-2025) (K MT)
Table North America Pregabalin Sales Market Share by Type (2016-2025)
Figure 2017 North America Pregabalin Market Share by Type
Table North America Pregabalin Sales by Application (2016-2025) (K MT)
Table North America Pregabalin Sales Market Share by Application (2016-2025)
Figure 2017 North America Pregabalin Market Share by Application
Table North America Pregabalin Sales by Company (2016-2018) (K MT)
Table North America Pregabalin Sales Market Share by Company (2016-2018)
Figure North America Pregabalin Sales Market Share by Company in 2017
Figure Europe Pregabalin Sales Growth Rate 2016-2025 (K MT)
Figure Europe Pregabalin Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Pregabalin Sales by Countries (2016-2025) (K MT)
Table Europe Pregabalin Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Pregabalin Sales Market Share by Countries
Table Europe Pregabalin Revenue by Countries (2016-2025) (Million US$)
Table Europe Pregabalin Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Pregabalin Revenue Market Share by Countries
Figure Germany Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Germany Pregabalin Revenue Growth Rate (2016-2025) (K MT)
Figure France Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure France Pregabalin Revenue Growth Rate (2016-2025) (K MT)
Figure UK Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure UK Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Italy Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Russia Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Pregabalin Sales by Type (2016-2025) (K MT)
Table Europe Pregabalin Sales Market Share by Type (2016-2025)
Figure 2017 Europe Pregabalin Market Share by Type
Table Europe Pregabalin Sales by Application (2016-2025) (K MT)
Table Europe Pregabalin Sales Market Share by Application (2016-2025)
Figure 2017 Europe Pregabalin Market Share by Application
Table Europe Pregabalin Sales by Company (2016-2018) (K MT)
Table Europe Pregabalin Sales Market Share by Company (2016-2018)
Figure Europe Pregabalin Sales Market Share by Company in 2017
Figure Asia Pacific Pregabalin Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Pregabalin Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Pregabalin Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Pregabalin Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pregabalin Sales Market Share by Countries
Table Asia Pacific Pregabalin Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Pregabalin Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pregabalin Revenue Market Share by Countries
Figure China Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure China Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Japan Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Korea Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure India Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure India Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Australia Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Pregabalin Sales by Type (2016-2025) (K MT)
Table Asia Pacific Pregabalin Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Pregabalin Market Share by Type
Table Asia Pacific Pregabalin Sales by Application (2016-2025) (K MT)
Table Asia Pacific Pregabalin Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Pregabalin Market Share by Application
Table Asia Pacific Pregabalin Sales by Company (2016-2018) (K MT)
Table Asia Pacific Pregabalin Sales Market Share by Company (2016-2018)
Figure Asia Pacific Pregabalin Sales Market Share by Company in 2017
Figure Central & South America Pregabalin Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Pregabalin Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Pregabalin Sales by Countries (2016-2025) (K MT)
Table Central & South America Pregabalin Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pregabalin Sales Market Share by Countries
Table Central & South America Pregabalin Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Pregabalin Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pregabalin Revenue Market Share by Countries
Figure Brazil Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Pregabalin Sales by Type (2016-2025) (K MT)
Table Central & South America Pregabalin Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Pregabalin Market Share by Type
Table Central & South America Pregabalin Sales by Application (2016-2025) (K MT)
Table Central & South America Pregabalin Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Pregabalin Market Share by Application
Table Central & South America Pregabalin Sales by Company (2016-2018) (K MT)
Table Central & South America Pregabalin Sales Market Share by Company (2016-2018)
Figure Central & South America Pregabalin Sales Market Share by Company in 2017
Figure Middle East and Africa Pregabalin Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Pregabalin Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Pregabalin Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Pregabalin Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pregabalin Sales Market Share by Countries
Table Middle East and Africa Pregabalin Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Pregabalin Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pregabalin Revenue Market Share by Countries
Figure GCC Countries Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Pregabalin Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Pregabalin Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Pregabalin Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Pregabalin Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Pregabalin Market Share by Type
Table Middle East and Africa Pregabalin Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Pregabalin Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Pregabalin Market Share by Application
Table Middle East and Africa Pregabalin Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Pregabalin Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Pregabalin Sales Market Share by Company in 2017
Table Pfizer Inc. Company Details
Table Pfizer Inc. Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Inc. Recent Development
Table Torrent Pharmaceuticals Ltd. Company Details
Table Torrent Pharmaceuticals Ltd. Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Torrent Pharmaceuticals Ltd. Recent Development
Table Lupin Limited Company Details
Table Lupin Limited Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Lupin Limited Recent Development
Table Zydus Cadila Healthcare Ltd. Company Details
Table Zydus Cadila Healthcare Ltd. Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Zydus Cadila Healthcare Ltd. Recent Development
Table Cipla Limited Company Details
Table Cipla Limited Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Cipla Limited Recent Development
Table Genesis Remedies Company Details
Table Genesis Remedies Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Genesis Remedies Recent Development
Table Sanofi Company Details
Table Sanofi Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Medley Pharmaceuticals Limited Company Details
Table Medley Pharmaceuticals Limited Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Medley Pharmaceuticals Limited Recent Development
Table Genesis Biotec Inc. Company Details
Table Genesis Biotec Inc. Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Genesis Biotec Inc. Recent Development
Table Biomax Company Details
Table Biomax Pregabalin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Biomax Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Pregabalin Value Chain
Table Typical Suppliers of Key Pregabalin Raw Material
Table Pregabalin Customers List
Table Pregabalin Sales Channels
Table Pregabalin Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *